Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avecom is a Belgian environmental and industrial biotechnology company that develops and commercializes microbial process solutions for environmental remediation and biomass fermentation. The company specializes in biodegradation, biosynthesis, and engineering mixed microbial consortia to treat contaminated soil, water, and air, and to convert industrial side streams into biobased products. Its biomass fermentation activities include production-process development for single-cell proteins, biopolymers, and organic fertilizers, supported by lab, pilot, and small-scale manufacturing capabilities. Avecom originated as a spin-out from Ghent University and operates as an active private SME serving industrial partners through R&D, scale-up, and commercial services. While it operates in biotechnology, it is primarily focused on environmental and industrial applications rather than human therapeutics or healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avecom.